Systemic sclerosis: anabasum produces improvements│EULAR

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Anabasum provides significant and “medically meaningful” efficacy in systemic sclerosis (SSc) as assessed by the American College of Radiology Combined Response Index in diffuse cutaneous Systemic Sclerosis (ACR CRISS) score and its individual domains, with acceptable safety and...